INSIGHTS ON LIQUID DOSE MANUFACTURING
-
NanoImprove The Performance Of Your Formulations
Learn how Nanoforming can help improve the performance of your molecule by increasing drug loads, improving bioavailability, enhancing drug delivery profiles, and supporting product differentiation.
-
Drug Substance To Fill-Finish Handoff: What Sponsors Need To Know
Effective drug substance handoff to fill-finish manufacturing depends on early collaboration, clear communication, and proactive planning to reduce risks, ensure quality, and maintain timelines.
-
Vaccine Fill Line Operations
Learn how adopting a harmonized, risk-based validation strategy across global sites can reduce operational readiness timelines and drive improvements in equipment effectiveness and regulatory compliance
-
Ensuring Product Safety And Purity With Mycoplasma And Sterility Testing
Discover how the Applied Biosystems™ MycoSEQ™ Plus system and Applied Biosystems™ SteriSEQ™ Rapid Sterility Testing System can help accelerate your cell therapy manufacturing process.
-
From API Synthesis To Drug Product Shelf Life8/20/2026
Fragmented drug development causes delays and added costs. Unifying API synthesis, fill-finish, and testing streamlines logistics, preserves product data, and accelerates regulatory timelines.
-
Enhancing Automated Environmental Monitoring In Gloveless Isolators1/7/2026
Explore how automation and robotic-friendly solutions are transforming fill-and-finish operations and gain insights into gloveless processes, EM testing challenges, and collaborative innovations.
-
Inline Buffer Formulation Systems7/6/2026
Eliminate large storage tanks and optimize cleanroom space with automated inline buffer formulation. See how on-demand fluid handling provides precise, real-time pH and conductivity control.
-
Why Lower Endotoxin Levels Matter: Raising The Bar For Patient Safety And Product Quality5/12/2026
Strengthen patient safety and regulatory compliance with comprehensive endotoxin control strategies designed to support the evolving demands of injectable and advanced pharmaceutical products.
-
Practical USP <1665>/<665> Guide To E&L Risk Assessment2/17/2026
A practical USP <1665> and <665> framework helps manufacturers evaluate and manage extractables and leachables risk, supporting quality, safety, and regulatory compliance.
LIQUID DOSE MANUFACTURING SOLUTIONS
-
Our Bench Vision Unit has been developed to provide maximum flexibility, with the same software and component design as our automatic visual inspection equipment used on production lines throughout the world.
- Container range: ampoules, vials, cartridges, syringes
- Inspected products: water-like, viscous, suspensions
-
Discover a flexible, automation-ready microplate washer with precise control for ELISA, cell-based, and protein array assays that offers low-residue washing, regulatory compliance, and modular upgrades.
-
Traditional vials, ampoules, and cartridges are still the most popular delivery systems and the prefilled syringes are still experiencing the greatest growth in the market of any parenteral dosage form. Therefore, to advance the development program appropriately, pharmaceutical R&D scientists should effectively leverage the advantages offered by each form of packaging and dosage.
-
Discover an automated filtration and filling system designed to accurately and aseptically aliquot bulk product into multiple biocontainers or bottles.
-
From stick packs and packettes to multi-use, recloseable flexible packaging, engineered for performance, superior barrier protection, and standout shelf appeal.